Allergy Therapeutics PLC (LSE:AGY) - Share price


Stock Report

Allergy Therapeutics PLC AGY

Balance Sheet
20152016201720182019
Fiscal Year Ends30/06/201530/06/201630/06/201730/06/201830/06/2019
Assets
Non Current Assets
Intangible5.005.365.464.954.84
Tangible8.759.679.6710.1011.48
Investments-----
Other-----
Total16.9119.0719.7220.0921.87
Current Assets
Stock6.757.697.488.819.41
Debtors4.926.167.526.019.19
Cash and Securities21.2023.4122.1215.5327.44
Total33.7937.6137.4630.9346.63
Held for Disposal-----
Total Assets50.7056.6857.1851.0268.50
Liabilities and Equity
Liabilities
Current7.4212.5214.0214.6316.86
Non-Current-----
Total-----
Equity
Share Capital92.02102.99103.02103.02113.21
Reserves-59.39-74.66-75.21-82.60-79.89
Shareholders Funds34.4730.3229.9723.0337.56
Minorities-----
Total34.4730.3229.9723.0337.56
Total Liabilities and Equity50.7056.6857.1851.0268.50
Net Borrowings-19.52-20.04-18.80-12.48-25.00
Investment Ratios
Net Tangible Asset Val PS3.217.095.565.176.23
ROCE2.02-26.66-4.04-18.078.70
ROE0.44-40.35-8.23-28.4311.44
Gross Gearing4.8911.1011.1013.286.49
Cash61.5077.1973.8367.4473.06
Interest Cover x4.00-40.17-7.76-20.5522.36
Quick Ratio r3.522.362.111.472.17
Current Ratio r4.553.002.672.112.77
Borrowings
Total Borrowings1.683.373.333.062.44
Due < 1 Yr0.250.300.390.640.69
Due 1-2 Yrs-----
Due 2-5 Yrs1.002.21---
Due > 5 Yrs0.430.862.942.411.74

GBP in Millions except per share data.

AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2020 Morningstar. All rights reserved.